Breaking News
Translate

EBOLA: Merck, UNESCO and Cambridge University build research capacity in Africa

By Bartholomew Madukwe

The world’s oldest pharmaceutical and chemical company, Merck, in partnership with United Nations Educational, Scientific and Cultural Organisation (UNESCO), Cambridge University and University of Rome has intensified effort in the fight against Ebola, thereby committed to developing Africa as an international hub for research excellence and scientific innovation.

Through a summit titled UNESCO-Merck Africa Research Summit (MARS), the group aims to contribute to building research capacity in the African research community, with special focus on Ebola and other emergent infectious diseases.

“UNESCO-Merck Africa Research Summit 2015 will have scientific support from UNESCO, University of Cambridge, and University of Rome,” Merck stated.

The Summit which is scheduled to take place in Switzerland from 19th through 20th October, 2015 instructs African researchers who are specialized in HIV and Ebola to submit abstracts of their latest research works in respect of the issue at hand.

Also, both final year African PhD students and young investigators who are involved in HIV, Ebola and other infectious disease researches are free to summit abstracts.

The annual Summit would also address the vital role of research in the improvement and sustainable development of population health with particular emphasis on how to translate knowledge into action, in order to improve health and make an impact on the society.

Additionally, it intends providing a networking platform to improving global cooperation on health research and narrowing the disparities in health systems performance between developing and developed countries.

“MARS 2015 will create an African researchers’ network where there will be exchange of experience, knowledge, best practice (especially in Ebola management) and cooperation in future research and development projects”, Merck concluded. Saturday foreign affairs

 


Disclaimer

Comments expressed here do not reflect the opinions of vanguard newspapers or any employee thereof.